488 related articles for article (PubMed ID: 32113944)
1. Inhalation therapy devices for the treatment of obstructive lung diseases: the history of inhalers towards the ideal inhaler.
Sorino C; Negri S; Spanevello A; Visca D; Scichilone N
Eur J Intern Med; 2020 May; 75():15-18. PubMed ID: 32113944
[TBL] [Abstract][Full Text] [Related]
2. [Chinese expert consensus on standardized inhaler device application in stable chronic airway diseases (2023)].
Inhalation Therapy and Respiratory Rehabilitation Group, Respiratory Equipment Committee of China Association of Medical Equipment
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1055-1067. PubMed ID: 37914418
[TBL] [Abstract][Full Text] [Related]
3. Nebulized Therapies in COPD: Past, Present, and the Future.
Barjaktarevic IZ; Milstone AP
Int J Chron Obstruct Pulmon Dis; 2020; 15():1665-1677. PubMed ID: 32764912
[TBL] [Abstract][Full Text] [Related]
4. Practical problems with aerosol therapy in COPD.
Rau JL
Respir Care; 2006 Feb; 51(2):158-72. PubMed ID: 16441960
[TBL] [Abstract][Full Text] [Related]
5. FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy.
González-Torralba F; Baloira A; Abad A; Fuster A; García-Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL
Int J Chron Obstruct Pulmon Dis; 2022; 17():1005-1015. PubMed ID: 35547784
[TBL] [Abstract][Full Text] [Related]
6. Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion.
Baloira A; Abad A; Fuster A; García Rivero JL; García-Sidro P; Márquez-Martín E; Palop M; Soler N; Velasco JL; González-Torralba F
Int J Chron Obstruct Pulmon Dis; 2021; 16():1021-1033. PubMed ID: 33907390
[TBL] [Abstract][Full Text] [Related]
7. Inhalatory therapy training: a priority challenge for the physician.
Melani AS
Acta Biomed; 2007 Dec; 78(3):233-45. PubMed ID: 18330086
[TBL] [Abstract][Full Text] [Related]
8. Aerosol Delivery Devices for Obstructive Lung Diseases.
Pleasants RA; Hess DR
Respir Care; 2018 Jun; 63(6):708-733. PubMed ID: 29794206
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat Soft Mist inhaler.
Hodder R; Price D
Int J Chron Obstruct Pulmon Dis; 2009; 4():381-90. PubMed ID: 19888356
[TBL] [Abstract][Full Text] [Related]
10. Reducing carbon footprint of inhalers: analysis of climate and clinical implications of different scenarios in five European countries.
Pernigotti D; Stonham C; Panigone S; Sandri F; Ferri R; Unal Y; Roche N
BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34872967
[TBL] [Abstract][Full Text] [Related]
11. Advances in soft mist inhalers.
Komalla V; Wong CYJ; Sibum I; Muellinger B; Nijdam W; Chaugule V; Soria J; Ong HX; Buchmann NA; Traini D
Expert Opin Drug Deliv; 2023; 20(8):1055-1070. PubMed ID: 37385962
[TBL] [Abstract][Full Text] [Related]
12. A review of the development of Respimat Soft Mist Inhaler.
Dalby R; Spallek M; Voshaar T
Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
[TBL] [Abstract][Full Text] [Related]
13. Use of Respimat Soft Mist inhaler in COPD patients.
Anderson P
Int J Chron Obstruct Pulmon Dis; 2006; 1(3):251-9. PubMed ID: 18046862
[TBL] [Abstract][Full Text] [Related]
14. Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence.
Aggarwal B; Gogtay J
Expert Rev Respir Med; 2014 Jun; 8(3):349-56. PubMed ID: 24802511
[TBL] [Abstract][Full Text] [Related]
15. [Respimat®, first Soft Mist™ inhaler: new perspectives in the management of COPD].
Henriet AC; Marchand-Adam S; Mankikian J; Diot P
Rev Mal Respir; 2010 Dec; 27(10):1141-9. PubMed ID: 21163393
[TBL] [Abstract][Full Text] [Related]
16. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.
Brand P; Hederer B; Austen G; Dewberry H; Meyer T
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):763-70. PubMed ID: 19281091
[TBL] [Abstract][Full Text] [Related]
17. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices.
Roche N; Dekhuijzen PN
J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873
[TBL] [Abstract][Full Text] [Related]
18. The Respimat
Iwanaga T; Tohda Y; Nakamura S; Suga Y
Clin Drug Investig; 2019 Nov; 39(11):1021-1030. PubMed ID: 31377981
[TBL] [Abstract][Full Text] [Related]
19. Demystifying Dry Powder Inhaler Resistance with Relevance to Optimal Patient Care.
Capstick TGD; Gudimetla S; Harris DS; Malone R; Usmani OS
Clin Drug Investig; 2024 Feb; 44(2):109-114. PubMed ID: 38198116
[TBL] [Abstract][Full Text] [Related]
20. [Inhalation therapy with Respimat soft inhaler in patients with COPD and asthma].
Voshaar T; Hausen T; Kardos P; Köhler D; Schultze-Werninghaus G; Schürmann W; Vogelmeier C
Pneumologie; 2005 Jan; 59(1):25-32. PubMed ID: 15685486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
